IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes

Cell Proliferation

Volumn 48, Issue 2, 2015, Pages 187-197

  Hsieh, W L ^a   Huang, Y H ^b   Wang, T M ^b   Ming, Y C ^c   Tsai, C N ^a   Pang, J H S ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE 1; INTERFERON ALPHA INDUCIBLE PROTEIN 27; PEPTIDES AND PROTEINS; PROTEIN P53; UNCLASSIFIED DRUG; AMINOQUINOLINE DERIVATIVE; CDC25B PROTEIN, HUMAN; CDK1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EPIDERMAL GROWTH FACTOR; IFI27 PROTEIN, HUMAN; IMIQUIMOD; MEMBRANE PROTEIN; MULTIPROTEIN COMPLEX; PROTEIN TYROSINE PHOSPHATASE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HALF LIFE TIME; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN PHOSPHORYLATION; S PHASE CELL CYCLE CHECKPOINT; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; ENZYME ACTIVATION; GENETICS; METABOLISM; PHOSPHORYLATION; PSORIASIS; RNA INTERFERENCE; SKIN;

AMINOQUINOLINES; ANIMALS; APOPTOSIS; CDC25 PHOSPHATASES; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN A; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; HUMANS; KERATINOCYTES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PSORIASIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; S PHASE CELL CYCLE CHECKPOINTS; SKIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84923996098     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12168     Document Type: Article

References (52)

1. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC et al. (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J. Invest. Dermatol. 129, 79-88.
2. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N. Engl. J. Med. 361, 496-509.
3. Johnson-Huang LM, McNutt NS, Krueger JG, Lowes MA (2009) Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases. J. Clin. Immunol. 29, 247-256.
4. Wang F, Smith N, Maier L, Xia W, Hammerberg C, Chubb H et al. (2012) Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24. Br. J. Dermatol. 167, 92-102.
5. Garcia-Perez ME, Royer M, Duque-Fernandez A, Diouf PN, Stevanovic T, Pouliot R (2010) Antioxidant, toxicological and antiproliferative properties of Canadian polyphenolic extracts on normal and psoriatic keratinocytes. J. Ethnopharmacol. 132, 251-258.
6. Mason J, Mason AR, Cork MJ (2002) Topical preparations for the treatment of psoriasis: a systematic review. Br. J. Dermatol. 146, 351-364.
7. Hsieh WL, Lin YK, Tsai CN, Wang TM, Chen TY, Pang JH (2012) Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes. J. Dermatol. Sci. 67, 140-146.
8. Scarponi C, Butturini E, Sestito R, Madonna S, Cavani A, Mariotto S et al. (2014) Inhibition of inflammatory and proliferative responses of human keratinocytes exposed to the sesquiterpene lactones dehydrocostuslactone and costunolide. PLoS One 9, e107904.
9. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K et al. (2001) Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum. Mol. Genet. 10, 1793-1805.
10. Suomela S, Cao L, Bowcock A, Saarialho-Kere U (2004) Interferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers. J. Invest. Dermatol. 122, 717-721.
11. Veal CD, Clough RL, Barber RC, Mason S, Tillman D, Ferry B et al. (2001) Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J. Med. Genet. 38, 7-13.
12. Anderson KS, Petersson S, Wong J, Shubbar E, Lokko NN, Carlstrom M et al. (2010) Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris. Br. J. Dermatol. 163, 1085-1089.
13. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836-5845.
14. Jones PH, Watt FM (1993) Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73, 713-724.
15. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761-771.
16. McCawley LJ, O'Brien P, Hudson LG (1998) Epidermal growth factor (EGF)- and scatter factor/hepatocyte growth factor (SF/HGF)- mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9. J. Cell. Physiol. 176, 255-265.
17. Lin YK, Leu YL, Yang SH, Chen HW, Wang CT, Pang JH (2009) Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component. J. Dermatol. Sci. 54, 168-174.
18. Assefa Z, Van Laethem A, Garmyn M, Agostinis P (2005) Ultraviolet radiation-induced apoptosis in keratinocytes: on the role of cytosolic factors. Biochim. Biophys. Acta 1755, 90-106.
19. Hung MJ, Cherng WJ, Hung MY, Wu HT, Pang JH (2010) Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells. J. Hypertens. 28, 940-951.
20. Balato A, Lembo S, Mattii M, Schiattarella M, Marino R, De Paulis A et al. (2012) IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation. Exp. Dermatol. 21, 892-894.
21. Farkas A, Kemeny L, Szony BJ, Bata-Csorgo Z, Pivarcsi A, Kiss M et al. (2001) Dithranol upregulates IL-10 receptors on the cultured human keratinocyte cell line HaCaT. Inflamm. Res. 50, 44-49.
22. Ronpirin C, Tencomnao T (2012) Effects of the antipsoriatic drug dithranol on E2A and caspase-9 gene expression in vitro. Genet. Mol. Res. 11, 412-420.
23. Kim TG, Byamba D, Wu WH, Lee MG (2011) Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment. Exp. Dermatol. 20, 855-857.
24. Saelee C, Thongrakard V, Tencomnao T (2011) Effects of Thai medicinal herb extracts with anti-psoriatic activity on the expression on NF-kappaB signaling biomarkers in HaCaT keratinocytes. Molecules 16, 3908-3932.
25. Nanney LB, Stoscheck CM, Magid M, King LE Jr (1986) Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J. Invest. Dermatol. 86, 260-265.
26. Yam CH, Fung TK, Poon RY (2002) Cyclin A in cell cycle control and cancer. Cell. Mol. Life Sci. 59, 1317-1326.
27. Manchado E, Eguren M, Malumbres M (2010) The anaphase-promoting complex/cyclosome (APC/C): cell-cycle-dependent and -independent functions. Biochem. Soc. Trans. 38, 65-71.
28. Wu NL, Huang DY, Hsieh SL, Hsiao CH, Lee TA, Lin WW (2013) EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis. Biochim. Biophys. Acta 1832, 1538-1548.
29. Strom BO, Paulsen RE (2012) Apoptosis inducer NGFI-B is degraded by the proteasome and stabilized by treatment with EGF. Biochem. Biophys. Res. Commun. 417, 1292-1297.
30. Manente AG, Pinton G, Tavian D, Lopez-Rodas G, Brunelli E, Moro L (2011) Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stability. PLoS One 6, e25676.
31. Li FL, Xu R, Zeng QC, Li X, Chen J, Wang YF et al. (2012) Tanshinone IIA inhibits growth of keratinocytes through cell cycle arrest and apoptosis: underlying treatment mechanism of psoriasis. Evid. Based Complement. Alternat. Med. 2012, 927658.
32. Lai WW, Hsiao YP, Chung JG, Wei YH, Cheng YW, Yang JH (2011) Synergistic phototoxic effects of glycolic acid in a human keratinocyte cell line (HaCaT). J. Dermatol. Sci. 64, 191-198.
33. Stout GJ, Westdijk D, Calkhoven DM, Pijper O, Backendorf CM, Willemze R et al. (2005) Epidermal transit of replication-arrested, undifferentiated keratinocytes in UV-exposed XPC mice: an alternative to in situ apoptosis. Proc. Natl. Acad. Sci. USA 102, 18980-18985.
34. Neades R, Cox L, Pelling JC (1998) S-phase arrest in mouse keratinocytes exposed to multiple doses of ultraviolet B/A radiation. Mol. Carcinog. 23, 159-167.
35. De Boer L, Oakes V, Beamish H, Giles N, Stevens F, Somodevilla-Torres M et al. (2008) Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events. Oncogene 27, 4261-4268.
36. Henglein B, Chenivesse X, Wang J, Eick D, Brechot C (1994) Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc. Natl. Acad. Sci. USA 91, 5490-5494.
37. Strausfeld U, Labbe JC, Fesquet D, Cavadore JC, Picard A, Sadhu K et al. (1991) Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature 351, 242-245.
38. Timofeev O, Cizmecioglu O, Settele F, Kempf T, Hoffmann I (2010) Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition. J. Biol. Chem. 285, 16978-16990.
39. Lu Z, Hunter T (2010) Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors. Cell Cycle 9, 2342-2352.
40. Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9, 153-166.
41. Matsumoto A, Takeishi S, Kanie T, Susaki E, Onoyama I, Tateishi Y et al. (2011) p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell 9, 262-271.
42. Zhao H, Traganos F, Darzynkiewicz Z (2008) Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation. Cell Cycle 7, 3048-3055.
43. Meulmeester E, Pereg Y, Shiloh Y, Jochemsen AG (2005) ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. Cell Cycle 4, 1166-1170.
44. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF (1995) Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92, 5545-5549.
45. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA et al. (1993) p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14, 833-839.
46. Lee YJ, Tsai CH, Hwang JJ, Chiu SJ, Sheu TJ, Keng PC (2009) Involvement of a p53-independent and post-transcriptional up-regulation for p21WAF/CIP1 following destabilization of the actin cytoskeleton. Int. J. Oncol. 34, 581-589.
47. Lei X, Liu B, Han W, Ming M, He YY (2010) UVB-Induced p21 degradation promotes apoptosis of human keratinocytes. Photochem. Photobiol. Sci. 9, 1640-1648.
48. Martynova E, Pozzi S, Basile V, Dolfini D, Zambelli F, Imbriano C et al. (2012) Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63. Oncotarget 3, 132-143.
49. Balan V, Nelson DR, Sulkowski MS, Everson GT, Lambiase LR, Wiesner RH et al. (2006) Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C. Antivir. Ther. 11, 901-908.
50. Sixtos-Alonso MS, Sanchez-Munoz F, Sanchez-Avila JF, Martinez RA, Dominguez Lopez A, Vargas Vorackova F et al. (2011) IFN-stimulated gene expression is a useful potential molecular marker of response to antiviral treatment with Peg-IFNalpha 2b and ribavirin in patients with hepatitis C virus genotype 1. Arch. Med. Res. 42, 28-33.
51. Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, Drexhage HA, Versnel MA (2008) Systemic increase in type I interferon activity in Sjogren's syndrome: a putative role for plasmacytoid dendritic cells. Eur. J. Immunol. 38, 2024-2033.
52. Nzeusseu Toukap A, Galant C, Theate I, Maudoux AL, Lories RJ, Houssiau FA et al. (2007) Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum. 56, 1579-1588.